Address
Oakwood Medical Investors
10411 Clayton Road
Suite 302
St Louis, MO 63131
United States
Website
Recent investment activity
KANDO id: 30962
Funds managed
Fund | Type | Vintage | Currency | Committed capital |
---|---|---|---|---|
Oakwood Medical Investors V | 2008 | USD | 125,000,000 | |
Oakwood Medical Investors IV | 2004 | USD | 43,000,000 | |
Oakwood Medical Investors III | 2001 | USD | 24,000,000 | |
Oakwood Investors I | 1999 | USD | 4,000,000 | |
Oakwood Medical Investors II | 1999 | USD | 6,000,000 |
Funding rounds
Top investment portfolio themes
pharmaceuticals (1)
Investment activity status
Active investor
Selected investments
Displaying 1 - 21 of 21Company | Profile | Country | Date | Funding | ||
---|---|---|---|---|---|---|
Argos Therapeutics Inc | Series B | |||||
CryoCor Inc | N/A | |||||
Ekos Corp | Series C | |||||
EndoStim Inc | Medical device company developing devices to treat gastrointestinal and urological neuro-muscular disorders. | N/A | ||||
Inhibitex Inc | N/A | |||||
Insulet Corp | N/A | |||||
MedVantx Inc | N/A | |||||
Mitralign Inc | Percutaneous mitral valve repair system. | Series C | ||||
Stereotaxis Inc | Medical device company engaged in the field of image guided interventional surgery | N/A | ||||
TransMolecular Inc | TransMolecular is a biotechnology company. | N/A | ||||
ViaCyte Inc | N/A | |||||
Achillion Pharmaceuticals Inc | Biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. | N/A Initial investment | ||||
Adiana Inc | Series D | |||||
Aptus Endosystems Inc | N/A | |||||
AtheroGenics Inc | N/A | |||||
EndoGastric Solutions Inc | Series F | |||||
EndoGastric Solutions Inc | Series E | |||||
EndoGastric Solutions Inc | N/A | |||||
LipoScience Inc | Diagnostic company developing clinical applications of nuclear magnetic resonance (NMR) spectroscopy. | N/A | ||||
Sadra Medical Inc | Series C Follow-on investment | |||||
Sadra Medical Inc | Series B Initial investment |
Team
Employee | Position | |||
---|---|---|---|---|
Daniel A Burkhardt | [email protected] | |||
Jason A Darrah | Director
Research |
[email protected] | ||
Steven D Girouard | [email protected] | |||
Raul E Perez | [email protected] |